Oleg Nodelman, Director at Aktis Oncology, Inc. (AKTS), bought 2,350,728 shares at $18.00 ($40.0M) on 2026-01-12, disclosed to the SEC on 2026-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 128,506 | $0 | 0.0% |
| 2 | $18.00 | 144,443 | $2.6M | 6.5% |
| 3 | $18.00 | 2,077,779 | $37.4M | 93.5% |
| Total | $17.02 avg | 2,350,728 | $40.0M | 100% |
| Filing → |
| NUVB | BUY | 2023-09-21 | $6.7M | — | Filing → |
| ANAB | BUY | 2021-05-04 | $5.1M | — | Filing → |
| ANAB | BUY | 2021-04-27 | $3.5M | — | Filing → |